Clinical Scientific Expert I

A rare chance has emerged for qualified candidates to join Novartis as a Clinical Scientific Expert I in India. This role involves contributing to global clinical trial activities, ensuring compliance with regulatory requirements, and providing clinical and scientific support throughout all phases of a clinical study.

About Novartis

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. With a focus on innovative medicines, Novartis operates in various therapeutic areas, including oncology, cardiology, and immunology. The organization is committed to improving patient outcomes through research and development, making significant contributions to the pharmaceutical industry.

Job ID: REQ-10087722

Location: India

Application Deadline: 15 September 2026

Job Description

The Clinical Scientific Expert I (CSE I) provides clinical and scientific support through all phases of a clinical study under the guidance of the (A)CD(M)D in compliance with Novartis processes, ICH GCP, and regulatory requirements. This role applies the principles of clinical data review excellence and identifies clinical data insights to ensure data is scientifically plausible and to identify trends, signals, and risks associated with trial endpoints and patient safety.

Key Responsibilities

• Perform high-quality clinical data review and identify clinical data insights through patient-level review and trends analysis, supporting Interim Analysis, Database, and Post Lock activities, and facilitate resolution of clinical data issues.
• Contribute to the development of the Data Review/Quality Plan (DRP/DQP) and data review strategy, ensuring consistent implementation of protocol-level deviations and eligibility criteria.
• In conjunction with relevant line functions, contribute to Case Report Form (CRF) development and support the implementation of data capture tools.
• Facilitate data review process improvements, including the identification of delinquent/redundant reports and implementation of innovative data analysis processes.
• May contribute to the development of study-level documents, including clinical sections of key regulatory documents, such as Investigator’s Brochures and submission dossiers.
• May support pharmacovigilance activities, including reviewing/contributing to aggregate reports and attending Safety Monitoring Meetings (SMT).
• Produce training materials and provide training to iCTT, supporting/presenting at study-level meetings as required.
• Develop subject matter expertise in disease area knowledge and clinical data review tools and processes.

Eligibility Criteria

• Advanced degree in life sciences/healthcare (or clinically relevant degree) is required. Master’s, PharmD, MPharm, PhD, MBBS, BDS, MD strongly preferred.
• 1-2 years of scientific, strategic, and operational experience in planning, executing, reporting, and publishing clinical studies in industry or academia, or 3-4 years in a Clinical Operations/Clinical Scientific role.
• Intermediate knowledge of planning, executing, reporting, and publishing global clinical studies in a pharmaceutical company or contract research organization.
• Good knowledge of Good Clinical Practice and drug development processes.
• Strong scientific knowledge in at least one therapeutic area, including understanding of basic mechanisms of diseases and associated symptoms.
• Knowledge of principles of clinical data collection and reporting; ability to use systems and tools for data collection, analysis, and reporting.
• Analytical/computational background; ability to detect data trends and escalate as appropriate.
• Ability to collaborate across boundaries for shared success and resolve issues or understand when to escalate.

How to Apply

CLICK HERE FOR THE ORIGINAL NOTIFICATION / APPLY ONLINE

Conclusion

This opportunity at Novartis for the Clinical Scientific Expert I role is ideal for candidates looking to advance their careers in clinical research and contribute to significant healthcare advancements. Interested applicants are encouraged to apply before the deadline of 15 September 2026.